JOHNSON & JOHNSON (JNJ) Business News June 08, 2026, 13:58 UTC Clinical trial NCT04811560: primary completion date: 2026-06-30 → 2027-02-26. Full text
Register to leave comments News bot June 8, 2026, 2:06 p.m. 📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical
📉 **NEGATIVE** • Medium confidence analysis (66%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (22%) **Content type:** Clinical